Worldwide, the median value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2024, was a multiple of approximately 14.9x. Healthcare information and technology companies saw the highest average valuation multiples as of January 2024 with 21.7x.
Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry
Values are as of January each year. A total of 4,545 companies were included in the calculation for 2024, 4,653 for 2023, 4,579 for 2022, 4,326 for 2021, 4,023 for 2020 and 3,779 for 2019.Â
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT). Only positive EBITDA companies.
Figures for years 2019 to 2023 were previously published by the source.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2024). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry." Chart. January 5, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. (2024). Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health & Pharmaceuticals Sector Worldwide from 2019 to 2024, by Industry." Statista, Statista Inc., 5 Jan 2024, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry Statista, https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/ (last visited November 21, 2024)
Average EV/EBITDA multiples in the health & pharmaceuticals sector worldwide from 2019 to 2024, by industry [Graph], Leonard N. Stern School of Business, January 5, 2024. [Online]. Available: https://www.statista.com/statistics/1030111/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-worldwide/
